# A Study to Evaluate the Efficacy and Safety of CP-101,606 in Subjects With an Acute Stroke

> **NCT00073476** · PHASE2 · TERMINATED · sponsor: **Pfizer** · enrollment: 300 (—)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** traxiprodil (CP-101,606)

## Key facts

- **NCT ID:** NCT00073476
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-09
- **Primary completion:** —
- **Final completion:** 2005-02
- **Target enrollment:** 300 (—)
- **Last updated:** 2006-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00073476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00073476, "A Study to Evaluate the Efficacy and Safety of CP-101,606 in Subjects With an Acute Stroke". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00073476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*